Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-03 · accession 0000875320-25-000240 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | 2025-12-03 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $449.00 | -347 | 15.3K | -2% | -$155.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | S | D | 347 | $449.00 | 15,306 | D | — | — |